ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Premenstrual Dysphoric Disorder (PMDD) Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-35Q132
Home | Market Reports | Health| Reproductive Health
Global Premenstrual Dysphoric Disorder PMDD Market Insights Forecast to 2028
BUY CHAPTERS

Global Premenstrual Dysphoric Disorder (PMDD) Market Insights, Forecast to 2030

Code: QYRE-Auto-35Q132
Report
December 2024
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
TEVA
Eli Liliy
Pfizer Inc
Bayer
GSK
Apotex
Bristol Laboratories
Mylan NV
Allergan plc

Premenstrual Dysphoric Disorder (PMDD) Market

Premenstrual dysphoric disorder (PMDD) is a health problem that is similar to premenstrual syndrome (PMS) but is more serious. PMDD causes severe irritability, depression, or anxiety in the week or two before your period starts. Symptoms usually go away two to three days after your period starts.
Market Analysis and Insights: Global Premenstrual Dysphoric Disorder (PMDD) Market
The global Premenstrual Dysphoric Disorder (PMDD) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Premenstrual Dysphoric Disorder (PMDD) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Premenstrual Dysphoric Disorder (PMDD) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Premenstrual Dysphoric Disorder (PMDD) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Premenstrual Dysphoric Disorder (PMDD) include Teva, Eli Liliy, Pfizer, Bayer, GSK, Apotex, Bristol Laboratories, Mylan and Allergan, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Premenstrual Dysphoric Disorder (PMDD) is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Premenstrual Dysphoric Disorder (PMDD) industry development. In 2023, global % revenue of Premenstrual Dysphoric Disorder (PMDD) went into Hospital filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Premenstrual Dysphoric Disorder (PMDD) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Premenstrual Dysphoric Disorder (PMDD), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Premenstrual Dysphoric Disorder (PMDD), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Premenstrual Dysphoric Disorder (PMDD) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Premenstrual Dysphoric Disorder (PMDD) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Premenstrual Dysphoric Disorder (PMDD) revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Premenstrual Dysphoric Disorder (PMDD) Market Report

Report Metric Details
Report Name Premenstrual Dysphoric Disorder (PMDD) Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Teva, Eli Liliy, Pfizer, Bayer, GSK, Apotex, Bristol Laboratories, Mylan, Allergan
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Premenstrual Dysphoric Disorder (PMDD) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Premenstrual Dysphoric Disorder (PMDD) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Premenstrual Dysphoric Disorder (PMDD) revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Premenstrual Dysphoric Disorder (PMDD) Market report?

Ans: The main players in the Premenstrual Dysphoric Disorder (PMDD) Market are Teva, Eli Liliy, Pfizer, Bayer, GSK, Apotex, Bristol Laboratories, Mylan, Allergan

What are the Application segmentation covered in the Premenstrual Dysphoric Disorder (PMDD) Market report?

Ans: The Applications covered in the Premenstrual Dysphoric Disorder (PMDD) Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Premenstrual Dysphoric Disorder (PMDD) Market report?

Ans: The Types covered in the Premenstrual Dysphoric Disorder (PMDD) Market report are Table Product, Inject Product, Others

Recommended Reports

Mental Health Treatments

Women's Health Disorders

Disorder Drug Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Table Product
1.2.3 Inject Product
1.2.4 Others
1.3 Market by Application
1.3.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Perspective (2019-2030)
2.2 Global Premenstrual Dysphoric Disorder (PMDD) Growth Trends by Region
2.2.1 Premenstrual Dysphoric Disorder (PMDD) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Premenstrual Dysphoric Disorder (PMDD) Historic Market Size by Region (2019-2024)
2.2.3 Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Region (2025-2030)
2.3 Premenstrual Dysphoric Disorder (PMDD) Market Dynamics
2.3.1 Premenstrual Dysphoric Disorder (PMDD) Industry Trends
2.3.2 Premenstrual Dysphoric Disorder (PMDD) Market Drivers
2.3.3 Premenstrual Dysphoric Disorder (PMDD) Market Challenges
2.3.4 Premenstrual Dysphoric Disorder (PMDD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Premenstrual Dysphoric Disorder (PMDD) by Players
3.1.1 Global Premenstrual Dysphoric Disorder (PMDD) Revenue by Players (2019-2024)
3.1.2 Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Players (2019-2024)
3.2 Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Premenstrual Dysphoric Disorder (PMDD), Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Premenstrual Dysphoric Disorder (PMDD) Market Concentration Ratio
3.4.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Premenstrual Dysphoric Disorder (PMDD) Revenue in 2023
3.5 Global Key Players of Premenstrual Dysphoric Disorder (PMDD) Head office and Area Served
3.6 Global Key Players of Premenstrual Dysphoric Disorder (PMDD), Product and Application
3.7 Global Key Players of Premenstrual Dysphoric Disorder (PMDD), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Premenstrual Dysphoric Disorder (PMDD) Breakdown Data by Type
4.1 Global Premenstrual Dysphoric Disorder (PMDD) Historic Market Size by Type (2019-2024)
4.2 Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Type (2025-2030)
5 Premenstrual Dysphoric Disorder (PMDD) Breakdown Data by Application
5.1 Global Premenstrual Dysphoric Disorder (PMDD) Historic Market Size by Application (2019-2024)
5.2 Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Premenstrual Dysphoric Disorder (PMDD) Market Size (2019-2030)
6.2 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
6.2.1 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2019-2024)
6.2.2 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2025-2030)
6.2.3 North America Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2019-2030)
6.3 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application
6.3.1 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2019-2024)
6.3.2 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2025-2030)
6.3.3 North America Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2019-2030)
6.4 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country
6.4.1 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2019-2024)
6.4.3 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size (2019-2030)
7.2 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
7.2.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2019-2024)
7.2.2 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2025-2030)
7.2.3 Europe Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2019-2030)
7.3 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application
7.3.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2019-2024)
7.3.2 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2025-2030)
7.3.3 Europe Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2019-2030)
7.4 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country
7.4.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2019-2024)
7.4.3 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Premenstrual Dysphoric Disorder (PMDD) Market Size (2019-2030)
8.2 China Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
8.2.1 China Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2019-2024)
8.2.2 China Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2025-2030)
8.2.3 China Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2019-2030)
8.3 China Premenstrual Dysphoric Disorder (PMDD) Market Size by Application
8.3.1 China Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2019-2024)
8.3.2 China Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2025-2030)
8.3.3 China Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Premenstrual Dysphoric Disorder (PMDD) Market Size (2019-2030)
9.2 Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
9.2.1 Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2019-2024)
9.2.2 Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2025-2030)
9.2.3 Asia Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2019-2030)
9.3 Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Application
9.3.1 Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2019-2024)
9.3.2 Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2025-2030)
9.3.3 Asia Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2019-2030)
9.4 Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Region
9.4.1 Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2019-2024)
9.4.3 Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Premenstrual Dysphoric Disorder (PMDD) Introduction
11.1.4 Teva Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024)
11.1.5 Teva Recent Developments
11.2 Eli Liliy
11.2.1 Eli Liliy Company Details
11.2.2 Eli Liliy Business Overview
11.2.3 Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Introduction
11.2.4 Eli Liliy Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024)
11.2.5 Eli Liliy Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Premenstrual Dysphoric Disorder (PMDD) Introduction
11.3.4 Pfizer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024)
11.3.5 Pfizer Recent Developments
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Premenstrual Dysphoric Disorder (PMDD) Introduction
11.4.4 Bayer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024)
11.4.5 Bayer Recent Developments
11.5 GSK
11.5.1 GSK Company Details
11.5.2 GSK Business Overview
11.5.3 GSK Premenstrual Dysphoric Disorder (PMDD) Introduction
11.5.4 GSK Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024)
11.5.5 GSK Recent Developments
11.6 Apotex
11.6.1 Apotex Company Details
11.6.2 Apotex Business Overview
11.6.3 Apotex Premenstrual Dysphoric Disorder (PMDD) Introduction
11.6.4 Apotex Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024)
11.6.5 Apotex Recent Developments
11.7 Bristol Laboratories
11.7.1 Bristol Laboratories Company Details
11.7.2 Bristol Laboratories Business Overview
11.7.3 Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Introduction
11.7.4 Bristol Laboratories Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024)
11.7.5 Bristol Laboratories Recent Developments
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Mylan Business Overview
11.8.3 Mylan Premenstrual Dysphoric Disorder (PMDD) Introduction
11.8.4 Mylan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024)
11.8.5 Mylan Recent Developments
11.9 Allergan
11.9.1 Allergan Company Details
11.9.2 Allergan Business Overview
11.9.3 Allergan Premenstrual Dysphoric Disorder (PMDD) Introduction
11.9.4 Allergan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024)
11.9.5 Allergan Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
TEVA
Eli Liliy
Pfizer Inc
Bayer
GSK
Apotex
Bristol Laboratories
Mylan NV
Allergan plc
List of Tables
    Table 1. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Table Product
    Table 3. Key Players of Inject Product
    Table 4. Key Players of Others
    Table 5. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Region (2019-2024)
    Table 9. Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Region (2025-2030)
    Table 11. Premenstrual Dysphoric Disorder (PMDD) Market Trends
    Table 12. Premenstrual Dysphoric Disorder (PMDD) Market Drivers
    Table 13. Premenstrual Dysphoric Disorder (PMDD) Market Challenges
    Table 14. Premenstrual Dysphoric Disorder (PMDD) Market Restraints
    Table 15. Global Premenstrual Dysphoric Disorder (PMDD) Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Share by Players (2019-2024)
    Table 17. Global Top Premenstrual Dysphoric Disorder (PMDD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premenstrual Dysphoric Disorder (PMDD) as of 2023)
    Table 18. Global Premenstrual Dysphoric Disorder (PMDD) Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Premenstrual Dysphoric Disorder (PMDD) Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Premenstrual Dysphoric Disorder (PMDD), Headquarters and Area Served
    Table 21. Global Key Players of Premenstrual Dysphoric Disorder (PMDD), Product and Application
    Table 22. Global Key Players of Premenstrual Dysphoric Disorder (PMDD), Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Type (2019-2024)
    Table 26. Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Type (2025-2030)
    Table 28. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Share by Application (2019-2024)
    Table 30. Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Share by Application (2025-2030)
    Table 32. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Premenstrual Dysphoric Disorder (PMDD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Premenstrual Dysphoric Disorder (PMDD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Premenstrual Dysphoric Disorder (PMDD) Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Teva Company Details
    Table 65. Teva Business Overview
    Table 66. Teva Premenstrual Dysphoric Disorder (PMDD) Product
    Table 67. Teva Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024) & (US$ Million)
    Table 68. Teva Recent Developments
    Table 69. Eli Liliy Company Details
    Table 70. Eli Liliy Business Overview
    Table 71. Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Product
    Table 72. Eli Liliy Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024) & (US$ Million)
    Table 73. Eli Liliy Recent Developments
    Table 74. Pfizer Company Details
    Table 75. Pfizer Business Overview
    Table 76. Pfizer Premenstrual Dysphoric Disorder (PMDD) Product
    Table 77. Pfizer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024) & (US$ Million)
    Table 78. Pfizer Recent Developments
    Table 79. Bayer Company Details
    Table 80. Bayer Business Overview
    Table 81. Bayer Premenstrual Dysphoric Disorder (PMDD) Product
    Table 82. Bayer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024) & (US$ Million)
    Table 83. Bayer Recent Developments
    Table 84. GSK Company Details
    Table 85. GSK Business Overview
    Table 86. GSK Premenstrual Dysphoric Disorder (PMDD) Product
    Table 87. GSK Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024) & (US$ Million)
    Table 88. GSK Recent Developments
    Table 89. Apotex Company Details
    Table 90. Apotex Business Overview
    Table 91. Apotex Premenstrual Dysphoric Disorder (PMDD) Product
    Table 92. Apotex Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024) & (US$ Million)
    Table 93. Apotex Recent Developments
    Table 94. Bristol Laboratories Company Details
    Table 95. Bristol Laboratories Business Overview
    Table 96. Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Product
    Table 97. Bristol Laboratories Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024) & (US$ Million)
    Table 98. Bristol Laboratories Recent Developments
    Table 99. Mylan Company Details
    Table 100. Mylan Business Overview
    Table 101. Mylan Premenstrual Dysphoric Disorder (PMDD) Product
    Table 102. Mylan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024) & (US$ Million)
    Table 103. Mylan Recent Developments
    Table 104. Allergan Company Details
    Table 105. Allergan Business Overview
    Table 106. Allergan Premenstrual Dysphoric Disorder (PMDD) Product
    Table 107. Allergan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024) & (US$ Million)
    Table 108. Allergan Recent Developments
    Table 109. Research Programs/Design for This Report
    Table 110. Key Data Information from Secondary Sources
    Table 111. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Type: 2023 VS 2030
    Figure 3. Table Product Features
    Figure 4. Inject Product Features
    Figure 5. Others Features
    Figure 6. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Application: 2023 VS 2030
    Figure 8. Hospital Case Studies
    Figure 9. Clinic Case Studies
    Figure 10. Others Case Studies
    Figure 11. Premenstrual Dysphoric Disorder (PMDD) Report Years Considered
    Figure 12. Global Premenstrual Dysphoric Disorder (PMDD) Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Premenstrual Dysphoric Disorder (PMDD) Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Region: 2023 VS 2030
    Figure 15. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Players in 2023
    Figure 16. Global Top Premenstrual Dysphoric Disorder (PMDD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premenstrual Dysphoric Disorder (PMDD) as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Premenstrual Dysphoric Disorder (PMDD) Revenue in 2023
    Figure 18. North America Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2019-2030)
    Figure 20. North America Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2019-2030)
    Figure 21. North America Premenstrual Dysphoric Disorder (PMDD) Market Share by Country (2019-2030)
    Figure 22. United States Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2019-2030)
    Figure 26. Europe Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2019-2030)
    Figure 27. Europe Premenstrual Dysphoric Disorder (PMDD) Market Share by Country (2019-2030)
    Figure 28. Germany Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Premenstrual Dysphoric Disorder (PMDD) Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2019-2030)
    Figure 36. China Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2019-2030)
    Figure 37. Asia Premenstrual Dysphoric Disorder (PMDD) Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2019-2030)
    Figure 39. Asia Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2019-2030)
    Figure 40. Asia Premenstrual Dysphoric Disorder (PMDD) Market Share by Region (2019-2030)
    Figure 41. Japan Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Premenstrual Dysphoric Disorder (PMDD) Market Share by Country (2019-2030)
    Figure 51. Brazil Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Teva Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024)
    Figure 58. Eli Liliy Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024)
    Figure 59. Pfizer Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024)
    Figure 60. Bayer Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024)
    Figure 61. GSK Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024)
    Figure 62. Apotex Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024)
    Figure 63. Bristol Laboratories Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024)
    Figure 64. Mylan Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024)
    Figure 65. Allergan Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2019-2024)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Premenstrual Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global PMS And Menstrual Health Supplements Market Research Report 2024
Global Seasonal Affective Disorder Therapeutics Market Insights Forecast to 2030
Global Phelan McDermid Syndrome PMS Market Research Report 2024
Bipolar Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Polycystic Ovarian Syndrome PCOS Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dysthymia Clinical Trial Market Research Report 2024
Global Paroxetine Market Insights Forecast to 2030
Global Depression Drugs Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global SAD Lamp Market Insights Forecast to 2030
Global Premenstrual Syndrome Medicine Market Research Report 2025
Global Polycystic Ovary Syndrome PCOS Treatment Market Research Report 2024
Global Women Health Diagnostics Market Insights Forecast to 2030
Global Post Traumatic Stress Disorder PTSD Market Research Report 2024
Global Chronic Depressive Personality Disorder Treatment Market Research Report 2024
Global Pre Menstrual Syndrome Market Insights Forecast to 2030
Global Addison s Disease Treatment Market Insights Forecast to 2030
Global Women s Health Market Research Report 2025
Global Bipolar Disorder Therapeutics Drugs Market Insights Forecast to 2030
Global Menopause Drugs Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions